Medical Advocates for Social Justice
Lamivudine (Epivir)
 
Pediatric Data

HBV Infection/Disease
 HIV Infection/Disease
 
 
Lamivudine Main Page Main New/Newsworthy Home Page      
Last Update:  September 27, 2007
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
HBV Infection/Disease
 

     Journal Papers, Abstracts, and Commentaries

 
Serum hyaluronan and laminin level in children with chronic hepatitis B during long-term
lamivudine treatment.
Lebensztejn DM, Skiba E, Sobaniec-Lotowska ME, et al
Hepatogastroenterology. 2007 Apr-May;54(75):834-8.
 Abstract
 
Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with
chronic hepatitis B: the younger the better.
 Choe BH, Lee JH, Jang YC 
J Pediatr Gastroenterol Nutr. 2007 Jan;44(1):92-8.
 Abstract
 
Long-term lamivudine therapy for chronic hepatitis B infection in children
unresponsive to interferon.
Hartman C, Berkowitz D, Eshach-Adiv O, et al 
J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):494-8
 Abstract
 
Lamivudine and high-dose interferon alpha 2a combination treatment in naive HBeAg-positive
immunoactive chronic hepatitis B in children: an East Mediterranean center's experience.
Yilmaz A, Akcam M, Gelen T, Artan R.
Eur J Pediatr. 2006 Aug 31;
 Abstract
 
Lamivudine therapy for children with chronic hepatitis B.
Liberek A, Szaflarska-Poplawska A, et al 
World J Gastroenterol. 2006 Apr 21;12(15):2412-6.
 Abstract
 
Lamivudine and high-dose interferon-alpha combination therapy for naive children with
chronic hepatitis B infection.
Saltik-Temizel IN, Kocak N, Demir H. 
J Clin Gastroenterol. 2005 Jan;39(1):68-70.
Abstract
 
Response to Lamivudine Treatment in Children with Chronic Hepatitis B Virus Infection.
Hagmann S, Chung M, Rochford G, et al  
Clin Infect Dis. 2003 Dec 1;37(11):1434-1
 Abstract
 
Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon.
 Hartman C, Berkowitz D, Shouval D, et al.   
 Pediatr Infect Dis J 2003 Mar;22(3):224-229
 Abstract
 
Lamivudine: in children and adolescents with chronic hepatitis B virus infection.
Keam SJ, Scott LJ.
Paediatr Drugs 2002;4(10):687-94; discussion 695-6
 Abstract
 
A 1-year trial of lamivudine for chronic hepatitis B in children.
Zuccotti GV, Cucchi C, Gracchi V, et al.
J Int Med Res 2002 Mar-Apr;30(2):200-2
 Abstract
 
Clinical trial of lamivudine in children with chronic hepatitis B.
Jonas MM, Kelley DA, Mizerski , et al.
N Engl J Med 2002 May 30;346(22):1706-13
 Abstract
 

Interferon Alpha/Lamivudine

     Journal Papers, Abstracts, and Commentaries

  Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children.
Selimoglu MA, Aydogdu S, Unal F, et al
 Pediatr Int 2002 Aug;44(4):404-8
 Abstract
 
Comparison of treatments of chronic hepatitis B in children with lamivudine and alpha-interferon
combination and alpha-interferon alone.
Dikici B, Bosnak M, Bosnak V, et al
 Pediatr Int 2002 Oct;44(5):517-21
 Abstract
 
Lamivudine and interferon-alpha combination treatment of childhood patients with chronic
hepatitis B infection.
Dikici B, Bosnak M, Kara IH, et al
 Pediatr Infect Dis J 2001 Oct;20(10):988-92
 Abstract
 
HIV Infection/Disease
 
Treatment Guidelines
 US Treatment Guidelines
 		  
Treatment  Options
 
     News
 
  NEWS RELEASE
 FDA Grants Temporary Approval of Combination Pill (Generic Lamivudine, Stavudine
and Nevirapine) To Treat Pediatric HIV-1 Infection outside the United States
US FDA
August 13, 2007
 News Release
 
     Journal Papers, Abstracts, and Commentaries
 
 
Fixed Dose Combination of Lamivudine, Stavudine and Nevirapine in the Treatment of Pediatric HIV
Infection: A Preliminary Report.
Pensi T  
Indian Pediatr. 2007 Jul;44(7):519-21
 Abstract

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and
zidovudine/abacavir beyond 5 years in children.
Green H, Gibb DM, Walker AS, et al
AIDS. 2007 May 11;21(8):947-55.
 Abstract
 
Adherence and Acceptability of Once Daily Lamivudine and Abacavir in Human
Immunodeficiency Virus Type-1 Infected Children.
 Leprevost M, Green H, Flynn J, et al   
Pediatr Infect Dis J. 2006 Jun;25(6):533-537.
Abstract

     Conference Reports, Abstracts and Posters

 
Formulation development of novel fixed dose combination (FDC) of lamivudine, nevirapine and
zidovudine for pediatrics
 Raghuvanshi R.S, Garg M., Jaiswal A|
(4th IAS Conference)
 Abstract

Adherence and acceptability of once daily lamivudine and abacavir in
HIV-1 infected children.
LeProvost M., Flynn J., Green H., et al
 (3rd IAS Conference)
 Abstract

Lamivudine Main Page Main New/Newsworthy Home Page      

Lamivudine Pediatric Data